Blood test could predict dangerous side effects of cancer immunotherapy
NCT ID NCT07249060
Summary
This study aims to find a way to predict which cancer patients might develop serious side effects from immunotherapy drugs. Researchers will compare blood samples from 300 cancer patients starting immunotherapy with samples from 40 people who have autoimmune diseases. They are looking for specific signals in the blood, called interferons, that might act as an early warning system before side effects occur.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitario de Navarra
RECRUITINGPamplona, Navarre, 31008, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.